These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 7348083)

  • 1. [Treatment of outpatients with high doses of haloperidol].
    Shopsin B; Kline N
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol: fifteen years of clinical experience.
    Ayd FJ
    Dis Nerv Syst; 1972 Jul; 33(7):459-69. PubMed ID: 4675174
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term effects of haloperidol.
    Man PL
    Dis Nerv Syst; 1973 Feb; 34(2):113-8. PubMed ID: 4267586
    [No Abstract]   [Full Text] [Related]  

  • 5. Haloperidol update: 1975.
    Ayd FJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):14-22. PubMed ID: 1019142
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of haloperidol by -methyldopa in the treatment of schizophrenic patients.
    Chouinard G; Serrano PM; Tetreault L
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):473-83. PubMed ID: 4198310
    [No Abstract]   [Full Text] [Related]  

  • 7. Long term haloperidol therapy in outpatients.
    Dunlop E
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:87-94. PubMed ID: 4862423
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloperidol: a quarter century of experience.
    Settle EC; Ayd FJ
    J Clin Psychiatry; 1983 Dec; 44(12):440-8. PubMed ID: 6418723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical trial of delayed-action Akinophyl (Akineton)].
    Delteil P; Decreton C
    Ann Med Psychol (Paris); 1972 May; 1(5):696-709. PubMed ID: 5081113
    [No Abstract]   [Full Text] [Related]  

  • 10. Haloperidol in overt ambulatory schizophrenics.
    Darling HF
    Dis Nerv Syst; 1973; 34(7):364-7. PubMed ID: 4782293
    [No Abstract]   [Full Text] [Related]  

  • 11. Higher than usual dosage of haloperidol: a pilot study in 'back ward' schizophrenics.
    Tanghe A; Declercq H
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):50-3. PubMed ID: 798191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 14. To the incompatibility of haloperidol with lithium salts.
    Marhold J; Zimanová J; Lachman M; Král J; Vojtĕchovský M
    Act Nerv Super (Praha); 1974 Aug; 16(3):199-200. PubMed ID: 4420744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
    Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic use at adult ambulatory care visits by patients with mental health disorders in the United States, 1996-2003: national estimates and associated factors.
    Sankaranarayanan J; Puumala SE
    Clin Ther; 2007 Apr; 29(4):723-41. PubMed ID: 17617297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
    Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A
    Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
    Planche R
    Sem Hop; 1984 Mar; 60(13):944-8. PubMed ID: 6144185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased extrapyramidal symptoms with intravenous haloperidol.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    J Clin Psychiatry; 1987 Jul; 48(7):278-80. PubMed ID: 3597329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.